{"hands_on_practices": [{"introduction": "The assembly of the C3 convertase, C3bBb, is the central enzymatic step of the alternative pathway, and its formation is critically dependent on the presence of divalent cations. This exercise delves into the fundamental biochemistry of this process, challenging you to model how competition between different cations for a single binding site on the C3bB complex governs the rate of pathway activation. By deriving the rate expression from the law of mass action, you will gain a quantitative appreciation for how the ionic microenvironment, a key experimental variable, directly fine-tunes complement function [@problem_id:2896988].", "problem": "A research group is quantifying how buffer-imposed divalent cation conditions regulate formation of the Alternative Pathway (AP) C3 convertase via the cation-dependent binding of complement factor B to C3b. They design a kinetic assay in which the measured initial rate of C3a generation is proportional to the concentration of the cation-bound C3bB complex that can be cleaved by factor D. The system has a single divalent cation site on the C3b–factor B assembly. Consistent with established biochemical observations, the following statements hold:\n\n- The site can bind magnesium ions ($\\mathrm{Mg^{2+}}$), nickel ions ($\\mathrm{Ni^{2+}}$), or calcium ions ($\\mathrm{Ca^{2+}}$), but only the $\\mathrm{Mg^{2+}}$-bound complex is fully functional for AP activation, while the $\\mathrm{Ni^{2+}}$-bound complex is partially functional and the $\\mathrm{Ca^{2+}}$-bound complex is functionally inactive for AP activation.\n- The functional efficacy of the $\\mathrm{Ni^{2+}}$-bound state is a fixed fraction $\\alpha$ of the $\\mathrm{Mg^{2+}}$-bound state.\n- Under initial-rate conditions, the initial rate $v$ is proportional to the effective fraction of cation-occupied sites that are catalytically competent (with partial competence appropriately scaled by $\\alpha$).\n- Cation binding to the site follows the law of mass action with dissociation constants $K_{d,\\mathrm{Mg}}$, $K_{d,\\mathrm{Ni}}$, and $K_{d,\\mathrm{Ca}}$.\n\nTwo buffers are compared:\n\n- Buffer A (no ethylene glycol-bis(2-aminoethylether)-$N,N,N',N'$-tetraacetic acid (EGTA), physiological calcium present): measured free ion concentrations are $\\left[\\mathrm{Mg^{2+}}\\right]_{A} = 0.6\\,\\mathrm{mM}$, $\\left[\\mathrm{Ni^{2+}}\\right]_{A} = 0\\,\\mathrm{mM}$, and $\\left[\\mathrm{Ca^{2+}}\\right]_{A} = 1.2\\,\\mathrm{mM}$.\n- Buffer B (EGTA-$\\mathrm{Mg^{2+}}$ buffer suppressing free calcium, with trace nickel added): measured free ion concentrations are $\\left[\\mathrm{Mg^{2+}}\\right]_{B} = 1.0\\,\\mathrm{mM}$, $\\left[\\mathrm{Ni^{2+}}\\right]_{B} = 0.020\\,\\mathrm{mM}$, and $\\left[\\mathrm{Ca^{2+}}\\right]_{B} = 0.001\\,\\mathrm{mM}$.\n\nIndependent equilibrium measurements for the cation site on the C3b–factor B assembly give $K_{d,\\mathrm{Mg}} = 0.20\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ni}} = 0.050\\,\\mathrm{mM}$, and $K_{d,\\mathrm{Ca}} = 2.0\\,\\mathrm{mM}$. The partial efficacy of $\\mathrm{Ni^{2+}}$ is $\\alpha = 0.35$. Assume that factor D is not rate limiting and that $[\\mathrm{C3b}]$ and $[\\mathrm{B}]$ are fixed and sufficiently low that the fraction of cation-bound sites determines the proportional initial rate.\n\nStarting from the law of mass action and site conservation only (do not assume any pre-derived occupancy formula), derive an expression for the initial rate in each buffer in terms of the free ion concentrations and $K_{d}$ values, and compute the fold-change in initial rate $v_{B}/v_{A}$. Express your final answer as a dimensionless number and round to four significant figures.", "solution": "The problem statement has been evaluated and is found to be scientifically grounded, well-posed, and free of contradictions or ambiguities. It presents a standard biochemical problem of competitive ligand binding to a single site, which is a suitable basis for rigorous analysis. All necessary constants and conditions are provided. Therefore, a solution will be provided.\n\nThe core of the problem is to determine the relative catalytic rate under two different conditions, where the rate is governed by the occupancy of a protein binding site by competing divalent cations. The derivation must begin from fundamental principles as specified.\n\nLet $S$ represent the free cation-binding site on the complement C3b-factor B assembly, denoted as $\\mathrm{C3bB}$. Let $[S]_{tot}$ be the total concentration of these sites. The cations $\\mathrm{Mg^{2+}}$, $\\mathrm{Ni^{2+}}$, and $\\mathrm{Ca^{2+}}$ compete for this site. Let $S_{\\mathrm{Mg}}$, $S_{\\mathrm{Ni}}$, and $S_{\\mathrm{Ca}}$ represent the site bound by each respective cation.\n\nAccording to the principle of conservation of mass for the binding site, the total concentration of sites is the sum of the concentrations of the free and bound forms:\n$$[S]_{tot} = [S] + [S_{\\mathrm{Mg}}] + [S_{\\mathrm{Ni}}] + [S_{\\mathrm{Ca}}]$$\n\nThe binding of each cation $M$ (where $M$ is $\\mathrm{Mg^{2+}}$, $\\mathrm{Ni^{2+}}$, or $\\mathrm{Ca^{2+}}$) is described by a dissociation equilibrium:\n$$S_M \\rightleftharpoons S + M$$\nThe law of mass action applied to these equilibria gives the dissociation constants, $K_d$:\n$$K_{d,\\mathrm{Mg}} = \\frac{[S][\\mathrm{Mg^{2+}}]}{[S_{\\mathrm{Mg}}]}$$\n$$K_{d,\\mathrm{Ni}} = \\frac{[S][\\mathrm{Ni^{2+}}]}{[S_{\\mathrm{Ni}}]}$$\n$$K_{d,\\mathrm{Ca}} = \\frac{[S][\\mathrm{Ca^{2+}}]}{[S_{\\mathrm{Ca}}]}$$\n\nFrom these definitions, we can express the concentration of each bound state in terms of the free site concentration, $[S]$, and the free cation concentrations:\n$$[S_{\\mathrm{Mg}}] = \\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}$$\n$$[S_{\\mathrm{Ni}}] = \\frac{[S][\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}$$\n$$[S_{\\mathrm{Ca}}] = \\frac{[S][\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}$$\n\nSubstituting these expressions into the site conservation equation allows us to relate $[S]_{tot}$ to $[S]$:\n$$[S]_{tot} = [S] + \\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[S][\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[S][\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}$$\nFactoring out $[S]$ yields:\n$$[S]_{tot} = [S] \\left( 1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}} \\right)$$\n\nThe problem states that the initial rate, $v$, is proportional to the effective amount of catalytically competent complexes. The $\\mathrm{Mg^{2+}}$-bound complex is fully functional (efficacy $1$), the $\\mathrm{Ni^{2+}}$-bound complex is partially functional (efficacy $\\alpha$), and the $\\mathrm{Ca^{2+}}$-bound complex is inactive (efficacy $0$). The total effective concentration of active complexes is therefore $[S_{\\mathrm{Mg}}] + \\alpha[S_{\\mathrm{Ni}}]$.\nThus, the rate $v$ is given by:\n$$v = C \\cdot ([S_{\\mathrm{Mg}}] + \\alpha[S_{\\mathrm{Ni}}])$$\nwhere $C$ is a proportionality constant. Since the total concentration of sites $[S]_{tot}$ is constant for the experiment, it is convenient to work with fractional occupancies. Let $\\theta_M = [S_M]/[S]_{tot}$ be the fraction of total sites occupied by cation $M$. The rate is proportional to the effective fractional occupancy, $\\Phi_{eff}$:\n$$v \\propto \\Phi_{eff} = \\theta_{\\mathrm{Mg}} + \\alpha \\theta_{\\mathrm{Ni}}$$\nTo find an explicit expression for $\\Phi_{eff}$, we first derive the expression for the fractional occupancy of each species. For example, for $\\mathrm{Mg^{2+}}$:\n$$\\theta_{\\mathrm{Mg}} = \\frac{[S_{\\mathrm{Mg}}]}{[S]_{tot}} = \\frac{\\frac{[S][\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}}{[S] \\left( 1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}} \\right)} = \\frac{\\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nSimilarly for $\\mathrm{Ni^{2+}}$:\n$$\\theta_{\\mathrm{Ni}} = \\frac{\\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nThe effective fractional occupancy is then:\n$$\\Phi_{eff} = \\theta_{\\mathrm{Mg}} + \\alpha \\theta_{\\mathrm{Ni}} = \\frac{\\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\alpha \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}}}{1 + \\frac{[\\mathrm{Mg^{2+}}]}{K_{d,\\mathrm{Mg}}} + \\frac{[\\mathrm{Ni^{2+}}]}{K_{d,\\mathrm{Ni}}} + \\frac{[\\mathrm{Ca^{2+}}]}{K_{d,\\mathrm{Ca}}}}$$\nThe ratio of the rates in Buffer B versus Buffer A is simply the ratio of their respective effective fractional occupancies, as the proportionality constant cancels:\n$$\\frac{v_B}{v_A} = \\frac{\\Phi_{eff, B}}{\\Phi_{eff, A}}$$\n\nTo simplify calculations, we define the dimensionless normalized concentration for each cation $M$ as $\\chi_M = [M]/K_{d,M}$.\nThe expression for $\\Phi_{eff}$ becomes:\n$$\\Phi_{eff} = \\frac{\\chi_{\\mathrm{Mg}} + \\alpha \\chi_{\\mathrm{Ni}}}{1 + \\chi_{\\mathrm{Mg}} + \\chi_{\\mathrm{Ni}} + \\chi_{\\mathrm{Ca}}}$$\n\nThe provided data are:\n$K_{d,\\mathrm{Mg}} = 0.20\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ni}} = 0.050\\,\\mathrm{mM}$, $K_{d,\\mathrm{Ca}} = 2.0\\,\\mathrm{mM}$, and $\\alpha = 0.35$.\n\nFor Buffer A:\n$[\\mathrm{Mg^{2+}}]_{A} = 0.6\\,\\mathrm{mM}$, $[\\mathrm{Ni^{2+}}]_{A} = 0\\,\\mathrm{mM}$, $[\\mathrm{Ca^{2+}}]_{A} = 1.2\\,\\mathrm{mM}$.\nThe normalized concentrations are:\n$$\\chi_{\\mathrm{Mg},A} = \\frac{0.6}{0.20} = 3.0$$\n$$\\chi_{\\mathrm{Ni},A} = \\frac{0}{0.050} = 0$$\n$$\\chi_{\\mathrm{Ca},A} = \\frac{1.2}{2.0} = 0.6$$\nThe effective fractional occupancy for Buffer A is:\n$$\\Phi_{eff, A} = \\frac{3.0 + (0.35)(0)}{1 + 3.0 + 0 + 0.6} = \\frac{3.0}{4.6}$$\n\nFor Buffer B:\n$[\\mathrm{Mg^{2+}}]_{B} = 1.0\\,\\mathrm{mM}$, $[\\mathrm{Ni^{2+}}]_{B} = 0.020\\,\\mathrm{mM}$, $[\\mathrm{Ca^{2+}}]_{B} = 0.001\\,\\mathrm{mM}$.\nThe normalized concentrations are:\n$$\\chi_{\\mathrm{Mg},B} = \\frac{1.0}{0.20} = 5.0$$\n$$\\chi_{\\mathrm{Ni},B} = \\frac{0.020}{0.050} = 0.4$$\n$$\\chi_{\\mathrm{Ca},B} = \\frac{0.001}{2.0} = 0.0005$$\nThe effective fractional occupancy for Buffer B is:\n$$\\Phi_{eff, B} = \\frac{5.0 + (0.35)(0.4)}{1 + 5.0 + 0.4 + 0.0005} = \\frac{5.0 + 0.14}{6.4005} = \\frac{5.14}{6.4005}$$\n\nFinally, we compute the fold-change in the initial rate:\n$$\\frac{v_B}{v_A} = \\frac{\\Phi_{eff, B}}{\\Phi_{eff, A}} = \\frac{5.14 / 6.4005}{3.0 / 4.6} = \\frac{5.14 \\times 4.6}{3.0 \\times 6.4005} = \\frac{23.644}{19.2015} \\approx 1.231364...$$\n\nRounding the result to four significant figures as requested yields $1.231$.", "answer": "$$\\boxed{1.231}$$", "id": "2896988"}, {"introduction": "The immense amplifying power of the alternative pathway stems not just from the formation of the C3 convertase, but from its functional lifetime. This practice explores the kinetics of convertase stability, focusing on the crucial role of Properdin (Factor P) as a stabilizing factor. You will use a two-state Markov model to derive the expected lifetime and total catalytic output of a single convertase, providing a concrete link between the molecular kinetics of stabilization and the overall efficiency of the complement cascade [@problem_id:2896993].", "problem": "A central amplification step in the alternative pathway of complement is the formation of the C3 convertase complex C3bBb, which cleaves C3 into C3a and C3b. Properdin (Factor P) binds and stabilizes C3bBb, prolonging its functional lifetime. Assume the following mechanistic base:\n\n- The active convertase exists in two interconverting states on the surface: an unstabilized state, denoted by $U$ (C3bBb), and a properdin-stabilized state, denoted by $S$ (C3bBbP). \n- Properdin binding to $U$ occurs with a second-order association rate constant $k_{\\text{on}}$ and a free properdin concentration $[P]$, giving a first-order binding rate $a = k_{\\text{on}}[P]$ (transition $U \\to S$). Properdin dissociation from $S$ occurs with a first-order rate constant $k_{\\text{off}}$ (transition $S \\to U$).\n- Inactivation (disassembly) of the convertase from $U$ and $S$ are independent, memoryless events with first-order rate constants $b$ and $d$, respectively. The corresponding half-lives are $t_{1/2,U}$ and $t_{1/2,S}$, such that $b = (\\ln 2)/t_{1/2,U}$ and $d = (\\ln 2)/t_{1/2,S}$.\n- While active (in either state $U$ or $S$), each convertase cleaves C3 at a constant catalytic turnover rate $k_{\\text{cat}}$; properdin binding does not change $k_{\\text{cat}}$.\n- Each convertase formation consumes one molecule of Factor B stoichiometrically. Define the efficiency as the expected number of C3 molecules cleaved per molecule of Factor B consumed; this equals the expected total number of C3 turnovers accomplished by a single convertase over its lifetime.\n\nStarting from these foundations, model the convertase lifetime as a continuous-time, two-state Markov process with absorption by inactivation. Derive, from first principles, the expected lifetime starting in $U$ at time $t=0$, and then compute the efficiency as $k_{\\text{cat}}$ times this expected lifetime, using the following experimentally plausible parameters:\n\n- Unstabilized convertase half-life $t_{1/2,U} = 90\\ \\mathrm{s}$.\n- Properdin-stabilized convertase half-life $t_{1/2,S} = 900\\ \\mathrm{s}$.\n- Properdin association rate constant $k_{\\text{on}} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$.\n- Properdin dissociation rate constant $k_{\\text{off}} = 2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}$.\n- Free properdin concentration $[P] = 50\\ \\mathrm{nM}$.\n- Convertase catalytic turnover $k_{\\text{cat}} = 15\\ \\mathrm{s}^{-1}$.\n\nExpress your final answer as the number of C3 molecules cleaved per Factor B consumed. Round your answer to three significant figures.", "solution": "The problem statement is scientifically grounded, well-posed, objective, and provides a complete and consistent set of parameters to model the lifetime of a C3 convertase. It is a valid problem in quantitative biology.\n\nThe system is modeled as a continuous-time Markov process with two transient states, $U$ (unstabilized) and $S$ (stabilized), and an absorbing state representing inactivation. The process begins in state $U$ at time $t=0$. The transitions are governed by first-order rate constants:\n- $U \\to S$: rate $a = k_{\\text{on}}[P]$\n- $S \\to U$: rate $k_{\\text{off}}$\n- $U \\to \\text{inactivated}$: rate $b$\n- $S \\to \\text{inactivated}$: rate $d$\n\nLet $P_U(t)$ and $P_S(t)$ be the probabilities that the convertase is in state $U$ or $S$ at time $t$, respectively, given it started in state $U$ at $t=0$. The time evolution of these probabilities is described by the following system of coupled linear ordinary differential equations:\n$$\n\\frac{dP_U(t)}{dt} = - (a+b)P_U(t) + k_{\\text{off}}P_S(t)\n$$\n$$\n\\frac{dP_S(t)}{dt} = aP_U(t) - (k_{\\text{off}}+d)P_S(t)\n$$\nThe initial conditions are $P_U(0)=1$ and $P_S(0)=0$, as the convertase is formed in the unstabilized state.\n\nThe expected lifetime of the convertase, starting from state $U$, which we denote as $E_U$, is the total time the system spends in any active state ($U$ or $S$) before inactivation. This can be calculated by integrating the total survival probability, $P_U(t) + P_S(t)$, from $t=0$ to $t=\\infty$:\n$$\nE_U = \\int_0^\\infty \\left( P_U(t) + P_S(t) \\right) dt\n$$\nThis can be expressed as the sum of the total time spent in state $U$, let's call it $T_U = \\int_0^\\infty P_U(t) dt$, and the total time spent in state $S$, $T_S = \\int_0^\\infty P_S(t) dt$.\n\nWe can find $T_U$ and $T_S$ by integrating the system of differential equations over the entire time course from $t=0$ to $t=\\infty$. For any state $i$, $\\int_0^\\infty \\frac{dP_i(t)}{dt} dt = P_i(\\infty) - P_i(0)$. Since inactivation is an absorbing state, $P_U(\\infty) = 0$ and $P_S(\\infty) = 0$.\n\nIntegrating the first equation:\n$$\n\\int_0^\\infty \\frac{dP_U(t)}{dt} dt = P_U(\\infty) - P_U(0) = 0 - 1 = -1\n$$\n$$\n-1 = - (a+b) \\int_0^\\infty P_U(t) dt + k_{\\text{off}} \\int_0^\\infty P_S(t) dt\n$$\n$$\n-1 = - (a+b)T_U + k_{\\text{off}}T_S\n$$\n\nIntegrating the second equation:\n$$\n\\int_0^\\infty \\frac{dP_S(t)}{dt} dt = P_S(\\infty) - P_S(0) = 0 - 0 = 0\n$$\n$$\n0 = a \\int_0^\\infty P_U(t) dt - (k_{\\text{off}}+d) \\int_0^\\infty P_S(t) dt\n$$\n$$\n0 = aT_U - (k_{\\text{off}}+d)T_S\n$$\n\nWe now have a system of two linear equations for $T_U$ and $T_S$:\n1. $(a+b)T_U - k_{\\text{off}}T_S = 1$\n2. $aT_U - (k_{\\text{off}}+d)T_S = 0$\n\nFrom equation (2), we express $T_S$ in terms of $T_U$:\n$$\nT_S = \\frac{a}{k_{\\text{off}}+d}T_U\n$$\nSubstitute this into equation (1):\n$$\n(a+b)T_U - k_{\\text{off}}\\left(\\frac{a}{k_{\\text{off}}+d}T_U\\right) = 1\n$$\n$$\nT_U \\left( (a+b) - \\frac{ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{(a+b)(k_{\\text{off}}+d) - ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{ak_{\\text{off}} + ad + bk_{\\text{off}} + bd - ak_{\\text{off}}}{k_{\\text{off}}+d} \\right) = 1\n$$\n$$\nT_U \\left( \\frac{ad + bk_{\\text{off}} + bd}{k_{\\text{off}}+d} \\right) = 1\n$$\nSolving for $T_U$:\n$$\nT_U = \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd}\n$$\nNow we find $T_S$:\n$$\nT_S = \\frac{a}{k_{\\text{off}}+d} \\left( \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd} \\right) = \\frac{a}{ad + bk_{\\text{off}} + bd}\n$$\nThe total expected lifetime $E_U$ is the sum of $T_U$ and $T_S$:\n$$\nE_U = T_U + T_S = \\frac{k_{\\text{off}}+d}{ad + bk_{\\text{off}} + bd} + \\frac{a}{ad + bk_{\\text{off}} + bd} = \\frac{a + k_{\\text{off}} + d}{ad + b k_{\\text{off}} + bd}\n$$\nThis is the symbolic expression for the expected lifetime starting from state $U$.\n\nNext, we calculate the numerical values of the rate constants using the given parameters:\n- $a = k_{\\text{on}}[P] = (2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}) \\times (50 \\times 10^{-9}\\ \\mathrm{M}) = 0.1\\ \\mathrm{s}^{-1}$\n- $b = \\frac{\\ln 2}{t_{1/2,U}} = \\frac{\\ln 2}{90}\\ \\mathrm{s}^{-1}$\n- $d = \\frac{\\ln 2}{t_{1/2,S}} = \\frac{\\ln 2}{900}\\ \\mathrm{s}^{-1}$\n- $k_{\\text{off}} = 2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1} = 0.02\\ \\mathrm{s}^{-1}$\n\nLet's compute the numerator and denominator of the expression for $E_U$:\nNumerator:\n$$\na + k_{\\text{off}} + d = 0.1 + 0.02 + \\frac{\\ln 2}{900} = 0.12 + \\frac{\\ln 2}{900}\\ \\mathrm{s}^{-1}\n$$\nDenominator:\n$$\nad + b k_{\\text{off}} + bd = (0.1)\\left(\\frac{\\ln 2}{900}\\right) + \\left(\\frac{\\ln 2}{90}\\right)(0.02) + \\left(\\frac{\\ln 2}{90}\\right)\\left(\\frac{\\ln 2}{900}\\right)\n$$\nWe can factor out $\\frac{\\ln 2}{900}$:\n$$\n\\text{Denominator} = \\frac{\\ln 2}{900} \\left( 0.1 + 10 \\times 0.02 + \\frac{\\ln 2}{90} \\right) = \\frac{\\ln 2}{900} \\left( 0.1 + 0.2 + \\frac{\\ln 2}{90} \\right) = \\frac{\\ln 2}{900} \\left( 0.3 + \\frac{\\ln 2}{90} \\right)\\ \\mathrm{s}^{-2}\n$$\nUsing $\\ln 2 \\approx 0.693147$:\n$b = \\frac{0.693147}{90} \\approx 0.0077016\\ \\mathrm{s}^{-1}$\n$d = \\frac{0.693147}{900} \\approx 0.00077016\\ \\mathrm{s}^{-1}$\nNumerator $\\approx 0.12 + 0.00077016 = 0.12077016\\ \\mathrm{s}^{-1}$\nDenominator $\\approx (0.1)(0.00077016) + (0.0077016)(0.02) + (0.0077016)(0.00077016)$\nDenominator $\\approx 0.000077016 + 0.000154032 + 0.0000059315 = 0.0002369795\\ \\mathrm{s}^{-2}$\n\n$$\nE_U \\approx \\frac{0.12077016}{0.0002369795} \\approx 509.613\\ \\mathrm{s}\n$$\nThe problem defines efficiency as the expected total number of C3 molecules cleaved, which is the product of the catalytic rate $k_{\\text{cat}}$ and the expected lifetime $E_U$.\n$$\n\\text{Efficiency} = k_{\\text{cat}} \\times E_U\n$$\nGiven $k_{\\text{cat}} = 15\\ \\mathrm{s}^{-1}$:\n$$\n\\text{Efficiency} = 15\\ \\mathrm{s}^{-1} \\times 509.613\\ \\mathrm{s} \\approx 7644.195\n$$\nThe problem requires the answer to be rounded to three significant figures.\n$$\n\\text{Efficiency} \\approx 7640\n$$\nIn scientific notation, this is $7.64 \\times 10^3$.", "answer": "$$\n\\boxed{7.64 \\times 10^3}\n$$", "id": "2896993"}, {"introduction": "A deep understanding of biological regulation enables powerful therapeutic design. This problem puts you in the role of a bioengineer designing a novel cancer immunotherapy based on a synthetic \"complement switch\" that manipulates the alternative pathway's regulatory machinery. By calculating the amplification gain of this switch, you will quantify how harnessing the opposing actions of the negative regulator, Factor H, and the positive regulator, Properdin, can transform a protected cell surface into a potent target for complement-mediated destruction [@problem_id:2273433].", "problem": "A novel cancer immunotherapy strategy involves a synthetic molecule called a Complement-Activating Redirected Immunomodulator (CARIM). This molecule is engineered to be anchored to cell membranes. The CARIM possesses two distinct functional states, which are switched by a protease that is exclusively expressed by tumor cells.\n\n1.  **Uncleaved State (on normal cells)**: The CARIM molecule presents a domain that binds the soluble complement regulatory protein, Factor H. This local recruitment of Factor H serves to protect the cell from complement-mediated damage. In this state, the decay of any spontaneously formed alternative pathway C3 convertase (C3bBb) is accelerated. The effective first-order rate constant for C3bBb decay on this protected surface is the sum of its intrinsic decay rate constant, $k_d$, and an additional rate constant, $k_{H}'$, due to the high local concentration of recruited Factor H.\n\n2.  **Cleaved State (on tumor cells)**: The tumor-specific protease cleaves the CARIM molecule, an action which exposes a new domain. This new domain avidly binds the soluble complement-stabilizing protein, Properdin. The local recruitment of Properdin significantly stabilizes the C3bBb convertase. This stabilization effect is modeled as a reduction in the intrinsic decay rate constant, such that the new effective decay rate becomes $k_d / (1 + \\gamma)$, where $\\gamma$ is a dimensionless stabilization factor.\n\nAssume a single C3bBb convertase has a catalytic rate of $k_{cat}$, meaning it generates $k_{cat}$ new C3b molecules per unit time. The therapeutic potential of this switch is quantified by the \"amplification gain,\" $G$, defined as the ratio of the total number of C3b molecules produced by a single C3bBb convertase over its entire lifetime in the cleaved (tumor) state to the total number produced in the uncleaved (protected) state.\n\nGiven the following parameters:\n- The intrinsic decay rate constant of C3bBb is $k_d = 0.0075\\ \\text{s}^{-1}$.\n- The effective decay acceleration rate constant due to recruited Factor H is $k_{H}' = 0.1725\\ \\text{s}^{-1}$.\n- The dimensionless stabilization factor from recruited Properdin is $\\gamma = 9.0$.\n\nCalculate the amplification gain, $G$. Round your final answer to three significant figures.", "solution": "The number of C3b molecules produced by a single C3bBb over its lifetime is the catalytic rate multiplied by the expected lifetime. For a first-order decay with effective rate constant $\\lambda$, the survival probability is $\\exp(-\\lambda t)$, so the expected total product is\n$$\nN=\\int_{0}^{\\infty} k_{cat}\\,\\exp(-\\lambda t)\\,dt=\\frac{k_{cat}}{\\lambda}.\n$$\nIn the uncleaved (protected) state, the effective decay rate is the sum of the intrinsic rate and the acceleration due to recruited Factor H:\n$$\n\\lambda_{\\text{uncleaved}}=k_{d}+k_{H}'.\n$$\nIn the cleaved (tumor) state, Properdin stabilizes the convertase, reducing the effective decay rate to\n$$\n\\lambda_{\\text{cleaved}}=\\frac{k_{d}}{1+\\gamma}.\n$$\nThus, the total C3b produced in each state is\n$$\nN_{\\text{uncleaved}}=\\frac{k_{cat}}{k_{d}+k_{H}'}, \\quad N_{\\text{cleaved}}=\\frac{k_{cat}(1+\\gamma)}{k_{d}}.\n$$\nThe amplification gain is the ratio\n$$\nG=\\frac{N_{\\text{cleaved}}}{N_{\\text{uncleaved}}}=\\frac{k_{cat}(1+\\gamma)/k_{d}}{k_{cat}/(k_{d}+k_{H}') }=(1+\\gamma)\\,\\frac{k_{d}+k_{H}'}{k_{d}}.\n$$\nSubstituting the given values $k_{d}=0.0075\\ \\text{s}^{-1}$, $k_{H}'=0.1725\\ \\text{s}^{-1}$, and $\\gamma=9.0$,\n$$\nG=(1+9.0)\\,\\frac{0.0075+0.1725}{0.0075}=10\\times\\frac{0.1800}{0.0075}=10\\times 24=240.\n$$\nRounded to three significant figures, this is $2.40\\times 10^{2}$.", "answer": "$$\\boxed{2.40 \\times 10^{2}}$$", "id": "2273433"}]}